載入...

Botulinum Toxin in Movement Disorders: An Update

Since its initial approval in 1989 by the US Food and Drug Administration for the treatment of blepharospasm and other facial spasms, botulinum toxin (BoNT) has evolved into a therapeutic modality for a variety of neurological and non-neurological disorders. With respect to neurologic movement disor...

全面介紹

Na minha lista:
書目詳細資料
發表在:Toxins (Basel)
Main Authors: Anandan, Charenya, Jankovic, Joseph
格式: Artigo
語言:Inglês
出版: MDPI 2021
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7827923/
https://ncbi.nlm.nih.gov/pubmed/33430071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins13010042
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!